As of Feb 27
| -0.23 / -2.90%|
The 3 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 30.00, with a high estimate of 34.00 and a low estimate of 20.00. The median estimate represents a +290.12% increase from the last price of 7.69.
The current consensus among 3 polled investment analysts is to Buy stock in OHR Pharmaceutical Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.